abstract |
A pharmaceutical composition comprising a pharmaceutically acceptable carrier, and as active ingredient 600 mg of (-) - 5- (3-chlorophenyl) -alpha- (4-chlorophenyl) -alpha- (1-methyl-1H-imidazol-5- il) tetrazolo [1,5a] quinazoline-7-methanamine or a pharmaceutically acceptable acid addition salt thereof. |